Compare SUVEN LIFE with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES TTK HEALTHCARE SUVEN LIFESCIENCES/
TTK HEALTHCARE
 
P/E (TTM) x 19.4 18.8 103.7% View Chart
P/BV x 3.9 1.5 262.3% View Chart
Dividend Yield % 0.5 1.0 52.0%  

Financials

 SUVEN LIFESCIENCES   TTK HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
TTK HEALTHCARE
Mar-19
SUVEN LIFESCIENCES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3381,215 27.8%   
Low Rs169610 27.8%   
Sales per share (Unadj.) Rs52.1444.4 11.7%  
Earnings per share (Unadj.) Rs6.817.2 39.6%  
Cash flow per share (Unadj.) Rs8.627.6 31.0%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Dividend yield (eoy) %0.60.5 108.0%  
Book value per share (Unadj.) Rs65.3177.9 36.7%  
Shares outstanding (eoy) m127.2814.13 900.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.1 236.8%   
Avg P/E ratio x37.152.9 70.2%  
P/CF ratio (eoy) x29.633.0 89.6%  
Price / Book Value ratio x3.95.1 75.7%  
Dividend payout %22.029.0 75.7%   
Avg Mkt Cap Rs m32,27212,894 250.3%   
No. of employees `0001.12.3 46.8%   
Total wages/salary Rs m6611,307 50.6%   
Avg. sales/employee Rs Th6,132.22,715.7 225.8%   
Avg. wages/employee Rs Th611.1565.3 108.1%   
Avg. net profit/employee Rs Th803.5105.4 762.3%   
INCOME DATA
Net Sales Rs m6,6356,279 105.7%  
Other income Rs m24278 312.6%   
Total revenues Rs m6,8776,356 108.2%   
Gross profit Rs m1,604496 323.7%  
Depreciation Rs m221147 150.9%   
Interest Rs m3834 111.5%   
Profit before tax Rs m1,587393 404.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718149 482.2%   
Profit after tax Rs m869244 356.8%  
Gross profit margin %24.27.9 306.3%  
Effective tax rate %45.237.9 119.3%   
Net profit margin %13.13.9 337.6%  
BALANCE SHEET DATA
Current assets Rs m6,2322,717 229.4%   
Current liabilities Rs m1,4901,571 94.9%   
Net working cap to sales %71.518.3 391.4%  
Current ratio x4.21.7 241.8%  
Inventory Days Days8632 268.8%  
Debtors Days Days8347 177.1%  
Net fixed assets Rs m4,043991 408.0%   
Share capital Rs m127141 90.1%   
"Free" reserves Rs m8,1832,373 344.8%   
Net worth Rs m8,3102,514 330.5%   
Long term debt Rs m183 523.5%   
Total assets Rs m10,3894,158 249.8%  
Interest coverage x43.112.6 341.7%   
Debt to equity ratio x00 158.4%  
Sales to assets ratio x0.61.5 42.3%   
Return on assets %8.76.7 130.8%  
Return on equity %10.59.7 107.9%  
Return on capital %19.516.9 115.2%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m5,622225 2,496.3%   
Fx outflow Rs m1,79971 2,530.5%   
Net fx Rs m3,822154 2,480.6%   
CASH FLOW
From Operations Rs m356173 205.4%  
From Investments Rs m-27997 -288.7%  
From Financial Activity Rs m-225-307 73.3%  
Net Cashflow Rs m-148-38 393.1%  

Share Holding

Indian Promoters % 63.4 65.4 96.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 0.0 5.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 25.8 141.5%  
Shareholders   37,287 12,723 293.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   PLETHICO PHARMA  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Sep 20, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS